IGF2BP3 was reported to bind to m6A-modified ABCB1 mRNA, leading to enhanced mRNA stability, and high ABCB1 expression subsequently triggered the multidrug resistance of CRC [115]. Here, IGF2BP3 is linked to colorectal carcinoma.